These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 7712476

  • 1. DNA damage in cyclophosphamide-resistant tumor cells: the role of glutathione.
    Richardson ME, Siemann DW.
    Cancer Res; 1995 Apr 15; 55(8):1691-5. PubMed ID: 7712476
    [Abstract] [Full Text] [Related]

  • 2. Paradoxical increase in DNA cross-linking in a human ovarian carcinoma cell line resistant to cyanomorpholino doxorubicin.
    Lau DH, Ross KL, Sikic BI.
    Cancer Res; 1990 Jul 01; 50(13):4056-60. PubMed ID: 2162251
    [Abstract] [Full Text] [Related]

  • 3. Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin.
    Lau DH, Lewis AD, Ehsan MN, Sikic BI.
    Cancer Res; 1991 Oct 01; 51(19):5181-7. PubMed ID: 1717140
    [Abstract] [Full Text] [Related]

  • 4. Cytotoxicity and DNA cross-linking activity of 4-sulfidocyclophosphamides in mouse leukemia cells in vitro.
    Erickson LC, Ramonas LM, Zaharko DS, Kohn KW.
    Cancer Res; 1980 Nov 01; 40(11):4216-20. PubMed ID: 7471062
    [Abstract] [Full Text] [Related]

  • 5. Depletion of cellular glutathione by N,N'-bis(trans-4-hydroxycyclohexyl)-N'-nitrosourea as a determinant of sensitivity of K562 human leukemia cells to 4-hydroperoxycyclophosphamide.
    Chresta CM, Crook TR, Souhami RL.
    Cancer Res; 1990 Jul 01; 50(13):4067-71. PubMed ID: 2354456
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
    Jain N, Lam YM, Pym J, Campling BG.
    Cancer; 1996 May 01; 77(9):1797-808. PubMed ID: 8646677
    [Abstract] [Full Text] [Related]

  • 7. Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance.
    Wang YY, Teicher BA, Shea TC, Holden SA, Rosbe KW, al-Achi A, Henner WD.
    Cancer Res; 1989 Nov 15; 49(22):6185-92. PubMed ID: 2804968
    [Abstract] [Full Text] [Related]

  • 8. Reduced levels of drug-induced DNA cross-linking in nitrogen mustard-resistant Chinese hamster ovary cells expressing elevated glutathione S-transferase activity.
    Robson CN, Lewis AD, Wolf CR, Hayes JD, Hall A, Proctor SJ, Harris AL, Hickson ID.
    Cancer Res; 1987 Nov 15; 47(22):6022-7. PubMed ID: 3664506
    [Abstract] [Full Text] [Related]

  • 9. Glutathione depletion as a determinant of sensitivity of human leukemia cells to cyclophosphamide.
    Crook TR, Souhami RL, Whyman GD, McLean AE.
    Cancer Res; 1986 Oct 15; 46(10):5035-8. PubMed ID: 3463410
    [Abstract] [Full Text] [Related]

  • 10. Characterization of acquired resistance to cis-diamminedichloroplatinum (II) in BE human colon carcinoma cells.
    Fram RJ, Woda BA, Wilson JM, Robichaud N.
    Cancer Res; 1990 Jan 01; 50(1):72-7. PubMed ID: 2293559
    [Abstract] [Full Text] [Related]

  • 11. Comparison of DNA interstrand cross-linking and strand breakage by 1,3-bis(2-chloroethyl)-1-nitrosourea in polyamine-depleted and control human adenocarcinoma cells.
    Seidenfeld J, Barnes D, Block AL, Erickson LC.
    Cancer Res; 1987 Sep 01; 47(17):4538-43. PubMed ID: 3113720
    [Abstract] [Full Text] [Related]

  • 12. The role of DNA damage in the resistance of human chronic myeloid leukemia cells to cyclophosphamide analogues.
    Andersson BS, Mroue M, Britten RA, Murray D.
    Cancer Res; 1994 Oct 15; 54(20):5394-400. PubMed ID: 7923171
    [Abstract] [Full Text] [Related]

  • 13. DNA interstrand cross-link and free radical formation in a human multidrug-resistant cell line from mitomycin C and its analogues.
    Dusre L, Rajagopalan S, Eliot HM, Covey JM, Sinha BK.
    Cancer Res; 1990 Feb 01; 50(3):648-52. PubMed ID: 2153443
    [Abstract] [Full Text] [Related]

  • 14. Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II).
    Teicher BA, Holden SA, Kelley MJ, Shea TC, Cucchi CA, Rosowsky A, Henner WD, Frei E.
    Cancer Res; 1987 Jan 15; 47(2):388-93. PubMed ID: 3539321
    [Abstract] [Full Text] [Related]

  • 15. Alkylator resistance in human B lymphoid cell lines: (1). Melphalan accumulation, cytotoxicity, interstrand-DNA-crosslinks, cell cycle analysis, and glutathione content in the melphalan-sensitive B-lymphocytic cell line (WIL2) and in the melphalan-resistant B-CLL cell line (WSU-CLL).
    Pu Q, Bianchi P, Bezwoda WR.
    Anticancer Res; 2000 Jan 15; 20(4):2561-8. PubMed ID: 10953327
    [Abstract] [Full Text] [Related]

  • 16. Differences between melphalan and nitrogen mustard in the formation and removal of DNA cross-links.
    Ross WE, Ewig RA, Kohn KW.
    Cancer Res; 1978 Jun 15; 38(6):1502-6. PubMed ID: 565677
    [Abstract] [Full Text] [Related]

  • 17. Direct relation of DNA lesions in multidrug-resistant human myeloma cells to intracellular doxorubicin concentration.
    Bellamy WT, Dorr RT, Dalton WS, Alberts DS.
    Cancer Res; 1988 Nov 15; 48(22):6360-4. PubMed ID: 3180055
    [Abstract] [Full Text] [Related]

  • 18. Lack of drug-induced DNA cross-links in chlorambucil-resistant Chinese hamster ovary cells.
    Jiang BZ, Bank BB, Hsiang YH, Shen T, Potmesil M, Silber R.
    Cancer Res; 1989 Oct 15; 49(20):5514-7. PubMed ID: 2551488
    [Abstract] [Full Text] [Related]

  • 19. Arabinosyl-2-fluoroadenine augments cisplatin cytotoxicity and inhibits cisplatin-DNA cross-link repair.
    Yang LY, Li L, Keating MJ, Plunkett W.
    Mol Pharmacol; 1995 May 15; 47(5):1072-9. PubMed ID: 7746274
    [Abstract] [Full Text] [Related]

  • 20. Relationship between DNA cross-links, cell cycle, and apoptosis in Burkitt's lymphoma cell lines differing in sensitivity to nitrogen mustard.
    O'Connor PM, Wassermann K, Sarang M, Magrath I, Bohr VA, Kohn KW.
    Cancer Res; 1991 Dec 15; 51(24):6550-7. PubMed ID: 1742728
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.